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Excessive activation of the AT1A receptor (AT1AR) by angiotensin II (Ang II) is implicated in the age-related
development of hypertension, diabetes, and kidney disease. AT1AR-deficient mice live longer and have lower
levels of oxidative stress thanwild-typemice (Benigni et al., 2009), suggesting a role for AT1AR signaling in the
aging process.Persistent and poorly regulated hyperten-
sion is a major risk factor for many of the
most prevalent age-related disorders that
limit life span, including cardiovascular
disease,stroke,kidneydisease,andneuro-
degenerative diseases. Angiotensin II (Ang
II), a peptide produced from renin via the
proteolytic activity of angiotensin convert-
ing enzyme (ACE), is a key component of
an endocrine/paracrine signaling system
that increases vasoconstriction and blood
pressure. Ang II functionally interacts with
two forms of G protein-coupled receptor
(GPCR), the AT1 or AT2 type receptors.
The A subtype of the AT1 receptor
(AT1AR) is located on the surface of vas-
cular smooth muscle cells, and its activa-
tion by Ang II results in elevated levels of
intracellular calcium, generation of reactive
oxygen species (ROS), and contraction
of the cells. Ang II therefore acts to increase
vascular pressure, and accordingly ACE
inhibitors and AT1AR antagonists have
proven to be highly effective for the treat-
ment of hypertension (Werner et al., 2008).
As maintaining cardiovascular health can
have a major impact on longevity in hu-
mans, Benigni et al. (2009) recently exam-
ined the consequences of disruption of
the AT1AR gene on aging of the cardiovas-
cular and renal organ systems in mice.
Strikingly, both the average and maximum
life spans of AT1AR-deficient mice were
increased by approximately 20%.At a gross level the AT1AR-deficient mice
demonstrated no significant alteration in
body weight, fasting blood glucose, heart
weight/body weight ratio, or activity levels
demonstrating an ability of the animal to
partly mitigate the loss of AT1AR with
respect to overall energy metabolism.
However, age-related pathologies in the
cardiovascular system, including athero-
sclerotic lesions and cardiac fibrosis,
were reduced in AT1AR-deficient mice
compared to wild-type control mice
(Benigni et al., 2009). While the cellular
structure and function of the kidneys and
pancreas were unaffected by AT1AR defi-
ciency, age-related changes in the liver
(degeneration of hepatocytes, vesicular
steatosis, and exudation) were reduced
in the AT1AR-deficient mice. The aging
process involves damage to cells by
ROS, probably as the result of both
increased free radical production and a
reduced ability of cells to protect them-
selves against the ROS (Bokov et al.,
2004). To determine whether the increased
longevity of AT1AR-deficient mice was
associated with reduced levels of oxida-
tive stress, levels of nitrotyrosine, a marker
of oxidative attack on cellular proteins,
were measured in the heart, artery, and
kidney tissues from young and old wild-
type mice and aged AT1AR-deficient
mice. In all three tissues, levels of oxidative
protein damage were increased by agingCell Metaboin wild-type mice, but not in the AT1AR-
deficient mice. Benigni et al. used only
20 AT1A-deficient and 10 wild-type male
mice of one mixed genetic background
for their life span studies, an unusually
small number of animals for such a study.
It will therefore be important to repeat the
experiments with larger numbers of mice
of more than one genetic background;
females should also be evaluated, as there
may be sex differences in the effects of
AT1AR signaling on aging. In addition,
a comprehensive assessment of how
other blood-borne metabolic factors and
hormones also change in response to the
loss of Ang II signaling may also provide
insights into the longevity mechanism.
The low-level oxidative damage in old
AT1AR-deficient mice may not be due to
reduced production of ROS because
numbers of mitochondria, a major source
of free radicals, were increased in cells
from the AT1AR-deficient mice. Instead,
the authors’ data suggest that the lack
of AT1AR-mediated signaling results in
increased production of proteins that
protect cells against free radical attack.
Indeed, the expression of two cytoprotec-
tive mitochondrial proteins, Nampt and
sirtuin 3, were increased in kidney cells
of old AT1AR-deficient mice compared to
old wild-type mice (Benigni et al., 2009).
Nampt is a NAD+ biosynthetic enzyme
that protects cells against genotoxiclism 9, May 6, 2009 ª2009 Elsevier Inc. 403
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PreviewsFigure 1. AT1AR Signaling Pathways That May Mediate Effects of Ang II on Age-Related Disease Etiology and Eventual Longevity
The angiotensin receptor (AT1R) is coupled to the GTP-binding protein Gq. One major downstream pathway involves protein kinase C-d (PKCd) Rho-GEF (guanine
exchange factor) and RhoA, resulting in the activation of ROCK (Rho-kinase). ROCK can promote inflammation by inducing the expression of the chemokine
monocyte chemoattractant protein-1 (MCP-1) and can also stimulate cell hypertrophy and migration by activating JNK (c-jun N-terminal kinase). In addition,
ROCK promotes the contraction of vascular smooth muscle cells via a kinase cascade that activates myosin light chain (MLC), which may contribute to hyper-
tension and vascular pathology. Activation of the AT1AR can also induce free radical (superoxide and peroxynitrite) production by stimulating membrane-asso-
ciated NADPH oxidase. The resulting ROS can cause oxidative damage to DNA, proteins, and lipids and can also activate the transcription factor NF-kB, which
induces the expression of proinflammatory cytokines. Activation of AT1R coupled to Gaq11 causes membrane inositol phospholipid (PIP2) hydrolysis, generating
inositol trisphosphate (IP3), which triggers Ca
2+ release from endoplasmic reticulum stores. This Ca2+ release then activates matrix metalloproteases such as
ADAM17, which cleaves heparin-binding epidermal growth factor (EGF) on the cell surface, releasing EGF—which binds and then activates EGF receptor tyrosine
kinase activity (TK). Receptors for the EGF receptor, and the insulin and insulin-like growth factor (IGF) receptors, are coupled to intracellular adaptor proteins
(Shc, Grb2, and Sos in the case of the EGF receptor, and IRS1 in the case of the insulin/IGF receptor) that activate the monomeric G protein Ras. Activation of
these growth factor receptors can also lead to activation of phosphatidylinositol-3 kinase (PI3K), which in turn can activate Akt kinase. Downstream targets of Akt
that may mediate effects of AT1AR on cellular aging include forkhead transcription factors (FHTF) and the mammalian target of rapamycin (mTOR).
Figure prepared by KC Alexander.stress (Yang et al., 2007), while sirtuin 3 is
a histone deacetylase that protects cells
against oxidative stress-induced apo-
ptosis (Sundaresan et al., 2008). Benigni
et al. (2009) did not evaluate levels of
Nampt and sirtuin 3 in the heart or blood
vessels, so it is unclear whether these
stress-resistance proteins contribute to
the reduced cardiovascular pathology in
aged AT1AR-deficient mice. Interestingly,
the effects of AT1AR deficiency on cellular
stress resistance are similar to the effects
of dietary energy restriction and exercise,
two conditions that can improve health
and longevity (Martin et al., 2007). An404 Cell Metabolism 9, May 6, 2009 ª2009impaired ability to efficiently adapt to
stressors is a common feature of the
aging process, and it will be of interest
to determine the cellular signaling path-
way(s) that mediate the apparent adverse
effects of Ang II on stress responses.
The AT1AR is a member of the
rhodopsin-like GPCRs and is primarily
associated with Gaq and Gai type
G proteins. Like many other receptors in
this superfamily, its activation can impact
a variety of signal transduction pathways
(Higuchi et al., 2007) (Figure 1). One
pathway involving the protein kinases
(Rho kinase) ROCK and (c-jun N-terminalElsevier Inc.kinase) JNK promotes inflammation and
cellular hypertrophy and migration, while
another can activate NADPH oxidase,
resulting in oxidative damage to DNA,
proteins, and lipids. The insulin/insulin-
like growth factor-1 (IGF-1) signaling
pathway is strongly implicated in aging
as mutations in the genes that encode
components of this pathway extend life
span in organisms ranging from worms
and flies to mice (Tatar et al., 2003). Ang
II signaling through an epidermal growth
factor receptor-mediated ‘‘transactiva-
tion’’ pathway activates components of
the insulin signaling pathway including
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Previewsthe Shc adaptor protein, phosphatidyl
inositol-3 kinase (PI3K), and Akt kinases.
Two substrates of Akt implicated in aging
are forkhead transcription factors (FHTF)
and the mammalian target of rapamycin
(mTOR). FHTF are inhibited by Akt, result-
ing in reduced cellular production of anti-
oxidant proteins, whereas mTOR is acti-
vated by Akt resulting in increased protein
synthesis and cell hypertrophy. It will be
important to establish which of the AT1AR
signaling pathways enhances cardiovas-
cular aging and whether AT1AR deficiency
suppresses age-related changes in other
tissues. In particular, the activation status
of p66Shc and mTOR should be evaluated
in tissues of the AT1AR-deficient mice in
light of the increased longevity of mice
lacking p66Shc (Purdom and Chen, 2003).
Is the increased longevity of AT1AR-
deficient mice simply the result of reduced
cardiovascular pathology as suggested
by the authors (Benigni et al., 2009)?
Mice rarely die from cardiovascular
disease—instead in laboratory settings
they typically succumb to cancers, infec-
tions, or renal disease (Brayton, 2007).
The observation that AT1AR deficiency
extended both average and maximumOsteoclasts Pump
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Osteoclasts are the primary cells th
releasing minerals to maintain calciu
highlights an important role for mito
ating a positive osteoclastogenic fe
Osteoclastic bone resorption plays a
critical role in normal bone remodeling
and calcium homeostasis. Osteoclasts
(OCLs) resorb bone by releasing hydrolytic
enzymes to degrade bone matrix and
secrete acid into a specialized extracellular
compartment, the ruffled border, by means
of an energy-dependent vacuolar proton
pump. Similar to other cells specializedlife span suggests that AT1AR signaling
may accelerate the aging process in cells
throughout the whole body rather than
affecting only age-related cardiovascular
disease. Although Ang II is best known
for its effects on cardiovascular and renal
cells, AT1AR are widely expressed in cells
of the nervous system where they may
influence neuroendocrine function, auto-
nomic/stress responses, and possibly
a range of behaviors, some of which may
be preferentially preserved during aging
in AT1AR-deficient mice. Moreover,
AT1AR have been shown to play an im-
portant role in tumor angiogenesis and
growth (Egami et al., 2003), which could
contribute to the extended survival of the
AT1AR-deficient mice. Finally, the findings
of Benigni et al. open the possibility that
ACE inhibitors and AT1AR antagonists
could increase the longevity of healthy
humans who may not present significant
hypertensive symptomology.
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